-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SPjWpS+ycXea5nhBYOeMNgYOUY/0e4tJVkIWVwHi6MnIAd3TI1FZMcru01bTeLJH yoOvEo8h1A52BQ+x1UTuiQ== 0001013762-06-000496.txt : 20060307 0001013762-06-000496.hdr.sgml : 20060307 20060307164628 ACCESSION NUMBER: 0001013762-06-000496 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060215 ITEM INFORMATION: Changes in Registrant.s Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060307 DATE AS OF CHANGE: 20060307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medefile International, Inc. CENTRAL INDEX KEY: 0000842013 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 850368333 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 033-25126-D FILM NUMBER: 06670586 BUSINESS ADDRESS: STREET 1: 2 RIDGEDALE AVENUE STREET 2: SUITE 217 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 BUSINESS PHONE: (973) 993-8001 MAIL ADDRESS: STREET 1: 2 RIDGEDALE AVENUE STREET 2: SUITE 217 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 FORMER COMPANY: FORMER CONFORMED NAME: OMNIMED INTERNATIONAL, INC. DATE OF NAME CHANGE: 20051122 FORMER COMPANY: FORMER CONFORMED NAME: BIO SOLUTIONS INTERNATIONAL INC DATE OF NAME CHANGE: 20010214 FORMER COMPANY: FORMER CONFORMED NAME: SEPTIMA ENTERPRISES INC DATE OF NAME CHANGE: 19920703 8-K/A 1 mar620068k.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 15, 2006 MEDEFILE INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 033-25126 D 85-0368333 (State or Other Jurisdiction (Commission File (I.R.S. Employer of Incorporation) Number) Identification Number) 2 Ridgedale Avenue, Suite 217 Cedar Knolls, NJ 07927 (Address of principal executive offices) (zip code) (973) 993-8001 (Registrant's telephone number, including area code) Copies to: Richard A. Friedman, Esq. Sichenzia Ross Friedman Ference LLP 1065 Avenue of the Americas New York, New York 10018 Phone: (212) 930-9700 Fax: (212) 930-9725 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS. ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT. On February 15, 2006, Lawrence Scharfman CPA (the "Former Accountant") was dismissed as the independent registered public accounting firm for Medefile International, Inc. (formerly Omnimed International, Inc. and Bio-Solutions International, Inc.)(the "Company"). The Company has engaged Russell Bedford Stefano Mirchandani LLP (the "New Accountant"), as its new independent registered public accounting firm. The Company's decision to engage the New Accountant was approved by its Board of Directors, and the New Accountant was engaged, on February 15, 2006. The Former Accountant was engaged on May 16, 2005. The report of the Former Accountant on the financial statements of the Company for the year ended June 30, 2005 did not contain an adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles for the most recent fiscal year, except that the report of the Former Accountant expressed substantial doubt regarding the Company's ability to continue as a going concern. During the Company's most recent fiscal year and the subsequent interim period through the date of resignation, there were no reportable events as the term is described in Item 304(a)(1)(iv) of Regulation S-B. During the Company's most recent fiscal year and the subsequent interim period through the date of dismissal, there were no disagreements with the Former Accountant on any matters of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which, if not resolved to the satisfaction of the Former Accountant would have caused it to make reference to the subject matter of the disagreements in connection with its report on these financial statements for that period. The Company did not consult with the New Accountant regarding the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and no written or oral advice was provided by the New Accountant that was a factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issues. The Company has requested that the Former Accountant furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the above statements. The requested letter is attached as Exhibit 16.1 to this amended Form 8-K. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (a) Financial statements of business acquired. Not applicable. (b) Pro forma financial information. Not applicable. (c) Exhibits Exhibit Number Description - -------- ------------------------------------------------------------------ 16.1 Letter from Former Accountant. 1 SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDEFILE INTERNATIONAL, INC. Dated: March 7, 2006 By: /s/ Milton Hauser -------------------------- Name: Milton Hauser Title: President, Chief Executive Officer 2 EX-16 2 mar620068kex161.txt Lawrence Scharfman & Co. CPA PC Certified Public Accountants 18 E. Sunrise Highway, #203 9608 Honey Bell Circle Freeport, NY 11520 Boynton Beach, FL 33437 Telephone: (516) 771-5900 Telephone: (561) 733-0296 Facsimile: (516) 740-0613 Facsimile: (516) 771-2598 March 6, 2006 Securities and Exchange Commission Office of the Chief Accountant 100 F Street, N.E. Washington, DC 20549-7561 RE: Medefile International, Inc. Ladies and Gentlemen: We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on February 15, 2006, that was filed by our former client, Medefile International, Inc., on Wednesday, February 22, 2006. We agree with the statements made in response to that Item insofar as they relate to our Firm. We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K/A. Very truly yours, /s/ Lawrence Scharfman ------------------------ Lawrence Scharfman CPA -----END PRIVACY-ENHANCED MESSAGE-----